Photo: Jhpiego

Chad

Since the early 1990s, we have worked in these technical areas:

Family Planning and Reproductive Health

Malaria Prevention and Treatment

Our impact

  • From 2011 to 2016, Jhpiego-trained health care providers in Chad saw 228,744 patients with fever, of whom 63% (144,626 people) were tested and confirmed to have malaria, and 82% (119,174 people) were treated according to national guidelines.
  • From 2011 to 2016, more than 109 community health volunteers provided malaria education to and helped refer approximately 420,000 people to health facilities for timely, appropriate treatment.
  • The percentage of deaths due to malaria in targeted district hospitals decreased by 14 percentage points, from 60% (in six district hospitals) in 2013 to 46% (in nine district hospitals) by December 2016.
  • The rates of intermittent preventive treatment of malaria during pregnancy increased from 2012 to 2016—from 37% to 79% for first-dose treatment and 28% to 56% for second-dose treatment.

Current programs


  • Improving the Quality of Malaria Control Services in Chad and Cameroon

    Malaria is the leading cause of morbidity and mortality in Chad and Cameroon, and is particularly dangerous for children and pregnant women. Currently, Jhpiego is strengthening the capacity of the Chadian and Cameroonian Ministries of Health, the National Malaria Control Programs, health care providers and community health volunteers to provide high-quality malaria prevention and treatment for nearly 1,180,000 people living in 10 malaria-endemic districts along ExxonMobil’s 1,070-kilometer pipeline. The nine districts are Doba, Bodo, Béboto, Bébédjia, Goré, Bessao, Laramanaye, Donia, Kara (in Chad), and Kribi (in Cameroon). In addition to leading the development of national-level malaria guidelines, training manuals and reference materials, Jhpiego has trained health care providers, supervisors and community health volunteers to provide health services and/or health messages. These interventions have resulted in provision of lifesaving treatment to people with confirmed cases of malaria and improved coverage for intermittent preventive treatment of malaria among pregnant women.

Current programs

Improving the Quality of Malaria Control Services in Chad and Cameroon

Malaria is the leading cause of morbidity and mortality in Chad and Cameroon, and is particularly dangerous for children and pregnant women. Currently, Jhpiego is strengthening the capacity of the Chadian and Cameroonian Ministries of Health, the National Malaria Control Programs, health care providers and community health volunteers to provide high-quality malaria prevention and treatment for nearly 1,180,000 people living in 10 malaria-endemic districts along ExxonMobil’s 1,070-kilometer pipeline. The nine districts are Doba, Bodo, Béboto, Bébédjia, Goré, Bessao, Laramanaye, Donia, Kara (in Chad), and Kribi (in Cameroon). In addition to leading the development of national-level malaria guidelines, training manuals and reference materials, Jhpiego has trained health care providers, supervisors and community health volunteers to provide health services and/or health messages. These interventions have resulted in provision of lifesaving treatment to people with confirmed cases of malaria and improved coverage for intermittent preventive treatment of malaria among pregnant women.

Current and recent donors


ExxonMobil Foundation
Global Fund to Fight AIDS, Tuberculosis and Malaria

Chad-related technical and programmatic resources

Our resources

Country contact

Kodjo Morgah, Country Director for Cameroon and Chad
Tel. 235.6220.1476
Quartier Moursal
Avenue Baloum Kondol
Porte 1012
N’Djamena, Chad